Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianshen Changchun Paste (健身长春膏) is an approved Traditional Chinese Medicine (TCM) product in China, developed and marketed by Hubei Wushi Pharmaceutical and other manufacturers. Formulated as an oral decoction paste, it contains a mixture of traditional herbal ingredients including red ginseng, astragalus, poria, prepared rehmannia root, and goji berry. It is indicated for replenishing qi and blood and nourishing the liver and kidneys, and is used to treat symptoms such as fatigue, dizziness, tinnitus, palpitations, insomnia, and memory decline. The product has been designated as a National Protected Traditional Chinese Medicine Variety in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianshen Changchun Paste.